Redesign Health IPO
Redesign Health is a healthcare startup studio that builds and launches new healthcare companies focused on improving patient outcomes and reducing costs. The company creates multiple healthcare ventures across different therapeutic areas and business models, offering investors exposure to a portfolio approach in health innovation.
Key Facts
| Industry | Healthcare Technology |
| Founded | 2018 |
| Headquarters | New York, NY |
| Employees | ~200 |
| Website | redesignhealth.com |
| Funding | Series A at $1.6B valuation. Total raised: $220M |
About Redesign Health
Redesign Health operates as a healthcare venture studio that builds, launches, and scales healthcare companies from the ground up. The company takes a systematic approach to healthcare innovation by identifying market gaps, assembling founding teams, and providing capital and operational support to create new healthcare solutions. Unlike traditional venture capital firms that invest in existing companies, Redesign Health actively conceives and develops healthcare startups across various sectors including digital health, medical devices, pharmaceuticals, and healthcare services.
The venture studio has launched dozens of healthcare companies, including notable ventures like Appriss Health (prescription drug monitoring), Essential (primary care), and Jasper Health (cancer care support). Redesign Health's portfolio companies have collectively raised over $1 billion in follow-on funding, demonstrating the studio's ability to create scalable healthcare businesses that attract significant investor interest and address critical healthcare challenges.
IPO Status
Redesign Health has not announced any plans for an initial public offering. As a startup studio model, the company focuses on building and spinning out multiple healthcare companies rather than operating as a single traditional business. This unique structure makes IPO timing and approach less straightforward compared to conventional companies, as value is created through the portfolio of companies being developed. The healthcare startup studio has raised funding to support its company-building activities, but there are no confirmed details about IPO considerations. Given the nature of its business model, Redesign Health may be more likely to see exits through the individual companies it creates rather than as a single public entity, though no specific exit strategy has been announced.
Competitors
Frequently Asked Questions
Does Redesign Health have a stock?
No, Redesign Health has not had an IPO and remains a private company. The healthcare startup studio continues to operate privately while building new healthcare ventures.
When is the Redesign Health IPO date?
Redesign Health has not announced an IPO date or timeline. As a startup studio, its unique business model makes traditional IPO timing unclear, with no confirmed details.
How can I buy Redesign Health stock?
You cannot buy Redesign Health stock as the company is privately held. The startup studio model may involve different exit approaches than traditional IPOs.
Stay Updated on the Redesign Health IPO
Get real-time alerts when Redesign Health files for an IPO, prices shares, or begins trading.
Get IPO Alerts